在COVID-19的糖尿病患者中血清sICAM-1和galactin-3水平
Busra Karahan1, Dogan Nasir Binici1, Omer Karasahin2
1Department of Internal Medicine, Erzurum Regional Training and Research Hospital, Erzurum 25240, Türkiye.
Viruses
|July 30, 2025
概括
可溶性细胞间粘附分子-1 (sICAM-1) 和加勒-3显示为COVID-19患者2型糖尿病 (T2D) 的诊断标记物具有前途. 然而,这些标志物并不能预测研究中的队列中的生存结果.
科学领域:
- 内分泌学 在内分泌学.
- 免疫学 免疫学 免疫学
- 传染性疾病 传染性疾病
背景情况:
- 2型糖尿病 (T2D) 是严重的COVID-19结局的重要危险因素.
- 需要生物标志物来评估COVID-19的T2D患者的疾病严重程度和预后.
研究的目的:
- 为了评估可溶性细胞间粘附分子-1 (sICAM-1) 和加勒-3的诊断和预后价值.
- 在T2D和COVID-19患者中评估这些标记物.
主要方法:
- 45名COVID-19的T2D患者和45名健康对照者的前性观察研究.
- 使用ELISA测量了sICAM-1和galectin-3的血清水平.
- 患者与对照者之间,以及幸存者与非幸存者之间生物标志物水平的比较.
主要成果:
- 与对照人群相比,COVID-19的T2D患者的 galectin-3 和 sICAM-1 血清水平显著升高 (p < 0.001).
- 在幸存者和不幸存者之间,加勒-3或sICAM-1水平没有显著差异 (p = 0.240和p = 0.266).
结论:
- 在COVID-19的T2D患者中,加勒-3和sICAM-1表现出比传统生物标志物更好的诊断效用.
- 高水平表明糖尿病COVID-19患者的系统性炎症.
- 加勒-3和sICAM-1之间的强烈相关性表明潜在的共享炎症途径.
更多相关视频
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
3.0K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K
Diabetes: Symptoms, Diagnosis, and Complications
694
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
694


